LncRNA RHPN1-AS1 modulates cholangiocarcinoma progression and is related with poor clinical outcomes through miR-345-5p/YAP1 axis

Withdrawal: L. Ma, T. Li, G. Liu, J. Wang, Z. Yin, J. Kang, LncRNA RHPN1-AS1 modulates cholangiocarcinoma progression and is related with poor clinical outcomes through miR-345-5p/YAP1 axis, J. Gastroenterol. Hepatol. 2021, (https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgh.15374). The above article, published online on December 16, 2020 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the journal Editor-in-Chief Prof. Joseph Sung, and John Wiley & Sons, Ltd. The Withdrawal has been agreed because the final article was not approved for publication by the authors.